Comparing the Pharmacodynamics of Nasal and Buccal Midazolam Using EEG.

Trial Profile

Comparing the Pharmacodynamics of Nasal and Buccal Midazolam Using EEG.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 06 Feb 2015

At a glance

  • Drugs Midazolam (Primary) ; Midazolam (Primary)
  • Indications Epilepsy
  • Focus Pharmacodynamics
  • Acronyms nMDZ-EEG
  • Most Recent Events

    • 03 Feb 2015 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
    • 16 Nov 2012 Planned End Date changed from 1 Apr 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 16 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top